Ivan Kairatov's expertise in biopharma, particularly in advancing technologies and innovation within the industry, positions him as a leading figure in the field of biomedical imaging. With a wealth of experience in research and development, Ivan's contributions have greatly impacted the realm of
In recent times, Sanofi's Sarclisa (isatuximab) has emerged as a promising advancement in the treatment of multiple myeloma (MM), a type of blood cancer. Approximately 46,000 new cases are diagnosed annually in Europe alone, making MM the second most prevalent blood cancer after non-Hodgkin
As the biopharmaceutical sector traverses the complex terrain of 2025, it encounters a multitude of challenges shaped by financial constraints, regulatory shifts, and evolving geopolitical dynamics. The industry is marked by notable changes detailed in Ernst & Young LLP's (EY) annual Biotech Beyond
Could an individual's genetic information hold the keys to personalized treatment for mood disorders like major depressive disorder and bipolar disorder? Advances in genetic research suggest this might soon be possible, offering the potential to revolutionize psychiatric care. By understanding a
The ongoing quest to treat mitochondrial diseases has achieved a revolutionary stride, enhancing possibilities within gene therapy landscapes through mitochondrial base editing (mtBE). Recent innovations by scientists at the University Medical Center Utrecht signify a substantial advancement in
How can artificial intelligence transform your doctor’s visit without stepping into the clinic? Remote medical consultations, commonly referred to as eVisits, have surged in popularity within the past few years. A fascinating study revealed that nearly 70% of patients now prefer virtual
The world has long been challenged by the persistence of per- and polyfluoroalkyl substances, commonly known as PFAS, due to their stubborn nature and resistance to environmental degradation. These chemicals are essential in numerous industrial applications, leading to an accumulation in ecosystems
In recent developments, Dupixent, co-developed by Sanofi and Regeneron, has emerged as a promising solution for individuals suffering from bullous pemphigoid (BP), a debilitating skin disorder predominantly impacting older adults. This drug's approval is seen as a groundbreaking advancement by
Amidst the intricate web of modern health challenges, the question of whether enhancing brain health can tangibly influence heart health and mitigate cancer risks casts new light on our understanding of interconnected wellness. Recent research underscores a profound link between enhancing brain
Can everyday choices like consuming plant-based foods really influence the effectiveness of cancer treatments? Recent studies have unveiled a surprising link between diet, gut bacteria, and cancer treatment outcomes, especially their impact on PI3K inhibitors used to treat solid tumors. These
